Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marijo Bilusic

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid TumorsJulius Strauss, Christopher R Heery, Joseph W Kim, et al.
Urology|December 3, 2014
Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?Reza Mehrazin, Zachary Piotrowski, Brian Egleston, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistanceLing Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, et al.
The Oncologist|December 27, 2019
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid TumorsJulie M Collins, Renee N Donahue, Yo-Ting Tsai, et al.
European Urology Oncology|October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with EnzalutamideShruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
Urologic Oncology|April 20, 2019
mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomySamuel A Gold, David J VanderWeele, Stephanie Harmon, et al.
Oncotarget|September 15, 2016
TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracyPhillip N Gray, Huy Vuong, Pei Tsai, et al.
The Oncologist|October 10, 2019
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced CancerMargaret E Gatti-Mays, Jason M Redman, Renee N Donahue, et al.
Cancer Research|October 10, 2024
Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate CancerLing Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, et al.
The Oncologist|March 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal CancerJason M Redman, Yo-Ting Tsai, Benjamin A Weinberg, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid TumorsJulius Strauss, Christopher R Heery, Joseph W Kim, et al.
Urology|December 3, 2014
Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?Reza Mehrazin, Zachary Piotrowski, Brian Egleston, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistanceLing Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, et al.
The Oncologist|December 27, 2019
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid TumorsJulie M Collins, Renee N Donahue, Yo-Ting Tsai, et al.
European Urology Oncology|October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with EnzalutamideShruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
Urologic Oncology|April 20, 2019
mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomySamuel A Gold, David J VanderWeele, Stephanie Harmon, et al.
Oncotarget|September 15, 2016
TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracyPhillip N Gray, Huy Vuong, Pei Tsai, et al.
The Oncologist|October 10, 2019
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced CancerMargaret E Gatti-Mays, Jason M Redman, Renee N Donahue, et al.
Cancer Research|October 10, 2024
Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate CancerLing Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, et al.
The Oncologist|March 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal CancerJason M Redman, Yo-Ting Tsai, Benjamin A Weinberg, et al.
Pageof 8